Welcome!
Life sciences
Singapore economy
Listing amendment for life sciences IPOs part of bigger aspiration
Hitting jackpot by betting on bioscience companies is not for the faint-hearted and the impatient
August 10, 2023
Company in the news
Life sciences company ClavystBio launches with aim to 'accelerate' industry in Singapore
The CLA Real Estate-established has committed US$220 million to six early-stage companies and three venture partners.
September 15, 2022
Broker's Calls
RHB upgrades Venture Corp to 'buy' on positive outlook
RHB's Jarick Seet has upgraded his rating on Venture Corp from “neutral” to “buy”, and expects a better 2H20 for the company.
October 21, 2020
Funds
The appeal of life sciences
Xeraya is the only active PE and venture capital firm in the country that focuses on life science investments. It currently has US$500 million under management.
February 28, 2020
Broker's Calls
Expect bigger FY17 dividends from Venture with better 3Q, says RHB
SINGAPORE (Sept 26): RHB Research is maintaining its “buy” call on Venture Corporation on expectations of a sequential improvement in the group’s upcoming 3Q17 results, while lifting its target price estimate to $19.70 from $14.70 previously.
September 26, 2017
Temasek's net portfolio value rises 14% to record $275 bil for FY17 ended March
SINGAPORE (July 11): Singapore state investment company Temasek has announced that its net portfolio value for the year ended March rose 14% to $275 billion.
July 11, 2017
Amid Singapore’s slowing economy, these life science professions are still high in demand
SINGAPORE (Nov 21): Despite Singapore’s slowing economy and volatile economic environment, the city state’s maturing life science industry continues to report a strong demand for talent, says Randstad Singapore.
November 21, 2016